What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?

Kidney International

Volumn 59, Issue 3, 2001, Pages 823-834

  Davin, Jean Claude ^a   Ten Berge, Ineke J ^a   Weening, Jan J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Allergy; Circulating chemokines; Crescents; Hypersensitivity; Immunological abnormalities; Leukocytes; Vasculitis

Indexed keywords

CHEMOKINE; IMMUNOGLOBULIN A;

ANAPHYLACTOID PURPURA; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HENOCH SCHOENLEIN PURPURA NEPHRITIS; HUMAN; HYPERSENSITIVITY; IMMUNOGLOBULIN A NEPHROPATHY; PRIORITY JOURNAL; REVIEW;

EID: 0035091922     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.059003823.x     Document Type: Article

References (148)

1. Über eine eigentümliche form von purpura
2. Nomenclature of systemic vasculitides: Proposal of an International Consensur Conference
3. Les dépôts intercapillaires d'IgA-IgG
4. Anaphylactoid purpura. II. Immunofluorescent and electron microscopy studies of the glomerular lesions
5. IgA nephropathy and Henoch-Schönlein syndrome occurring in the same patient
6. Berger disease: Henoch-Schönlein without the rash
7. The rheumatic poison: A survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura
8. Berger disease: Thirty years later
9. Combined report on regular dialysis and transplantation in Europe, XX, 1989
10. Fréquence et cause de l'-insuffisance rénale chez l'enfant
11. Primary and secondary forms of IgA nephritis and Schönlein-Henoch syndrome
12. IgA nephropathies
13. Berger's disease in children: Natural history and outcome
14. The nephritis of Henoch-Schönlein purpura
15. Henoch-Schönlein nephritis
16. Renal involvement in Henoch-Schönlein purpura: A multivariate analysis of prognostic factors
17. Schönlein-Henoch purpura in adult patients: Predictive factors for IgA glomerulonephritis in a retrospective of 57 cases
18. Schönlein-Henoch purpura
19. Clinical and laboratory features of IgA nephropathy
20. IgA nephropathy in children
21. Long-term follow-up of childhood Henoch-Schönlein nephritis
22. Renal involvement in Schönlein-Henoch purpura
23. Epidemiology of Schönlein-Henoch purpura
24. Natural history and treatment of idiopathic IgA nephropathy
25. IgAN in children from Japan
26. IgA nephropathy: Long-term prognosis for pediatric patients
27. Recurrence of IgA deposits/disease in grafts: An Australian Registry Survey 1980-1990
28. Long-term prognosis of Henoch-Schönlein nephritis in adults and children
29. Influence of age on Henoch Schönlein purpura
30. Henoch-Schönlein purpura remitting in pregnancy and during sex steroid therapy
31. Course of Henoch-Schönlein nephritis after renal transplantation: Report on ten patients and review of the literature
32. Associated diseases in IgA nephropathy
33. Adult Schönlein-Henoch purpura after enalapril
34. Adult Schönlein-Henoch purpura after lisinopril
35. Henoch-Schönlein induced by fluoroquinolones
36. Henoch-Schönlein purpura associated with ranitidine
37. Schönlein-Henoch purpura with necrotizing vasculitis after cocaine snorting
38. Carbamazepine-induced thrombocytopenia and leucopenia complicated by Henoch-Schönlein purpura symptoms
39. Henoch-Schönlein syndrome induced by carbidopa/levodopa
40. Henoch-Schönlein purpura and acute interstitial nephritis after intravenous vancomycin administration in a patient with a staphylococcal infection
41. Henoch-Schönlein purpura associated with acetyl salicylic acid
42. Squamous cell carcinoma of bronchus presenting with Henoch-Schönlein purpura
43. Henoch-Schönlein purpura secondary to trauma
44. Relapsing Henoch-Schönlein syndrome with renal involvement in a patient with an IgA monoclonal gammopathy
45. Henoch-Schönlein purpura with IgA nephropathy and abnormalities of IgA in a Wiskott-Aldrich syndrome carrier
46. Henoch-Schönlein disease with IgA nephropathy associated with chronic alcoholic liver disease
47. Henoch-Schönlein purpura and α-1-antitrypsin deficiency
48. IgG antineutrophil cytoplasmic antibodies in IgA nephropathy: A clinical variant
49. Immunoglobulin A1 and IgA nephropathy
50. Charge and size of mesangial IgA in IgA nephropathy
51. Predominant synthesis of IgA with lambda light chain in IgA nephropathy
52. Polymorphsinfiltrate glomeruli in mesangial IgA glomerulonephritis
53. IgA nephropathy: Morphologic expression and pathogenesis
54. Anaphylactoid purpura. I. Pathology of the skin and kidney and frequency of streptococcal infections
55. Occurrence of vascular IgA deposits in clinically normal skin of patients with renal disease
56. Henoch-Schönlein purpura: What does the "rash" look like in the gastrointestinal mucosa
57. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy
58. Anti-neutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura
59. IgA antineutrophil cytoplasmic antibody in Henoch-Schönlein purpura
60. Lack of IgA anti-neutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy
61. Fibronectin-immunoglobulin complexes in the early course of IgA and Henoch-Schönlein nephritis
62. Evidence that the interaction between circulating IgA and fibronectin is a normal process enhanced in IgA nephropathy
63. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy
64. Alteration in the O-linked glycosylation of IgA1 in children with Henoch-Schönlein purpura
65. Galactosylation of N- and O-linked carbohydrate moities of IgA 1 and 1gG in IgA nephropathy
66. Acute experimental glomerulonephritis induced by the glomerular deposition of circulating polymeric IgA-concanavalin A complexes
67. Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy
68. Circulating serum lectins of patients with IgA nephropathy stimulate IL-6 release from mesangial cells
69. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG
70. Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted tD patients with clinical nephritis
71. Similar disturbances of B-cell activity and regulatory T-cell function in Henoch-Schönlein purpura and systemic lupus erythematosus
72. Relation between biological IgA abnormalities and mesangial IgA deposits in isolated hematuria of childhood
73. Cytokine production by peripheral blood mononuclear cells in IgA nephropathy
74. Increase of IgA-specific switch T cells in patients with IgA nephropathy
75. Autologous mixed lymphocyte reaction and T-cell suppressor activity in patients with Henoch-Schönlein purpura and IgA nephropathy
76. Immunoregulatory factors in the pathogenesis of IgA nephropathy
77. Detection of cytokines mRNA-expressing cells in peripheral blood of patients with IgA nephropathy using non-radioactive in situ hybridization
78. Animal models as a mean to study IgA nephropathy
79. A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger's disease and Schönlein-Henoch syndrome
80. Circulating IgA-immune complexes in Henoch-Schönlein purpura: A longitudinal study of their relationship to disease activity and vascular deposition of IgA
81. IgA immune complexes in Henoch-Schönlein purpura
82. The specific detection of IgA in immune complexes
83. IgA interaction with the asialoglycoprotein receptor
84. IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis
85. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies
86. Increased levels of IgA1-IgG immune complexes and anti F(ab') 2 antibodies in patients with primary IgA nephropathy
87. Down-regulation of Fcα receptors on blood cells of IgA nephropathy patients: Evidence for a negative regulatory role of serum IgA
88. Clearance kinetics and fate of macromolecular IgA in patients IgA nephropathy
89. Defective in vivo Fc and C3b receptor function in IgA nephropathy
90. Sequential measurements of the reticulo-endothelial system function in Henoch-Schönlein disease in childhood. Correlation with various immunological parameters
91. Increased intestinal permeability to (51 Cr) EDTA is correlated with IgA immune complex-plasma levels in children with IgA-associated nephropathies
92. Sequential measurements of intestinal permeability to 51 Cr EDTA in children with Henoch-Schönlein purpura nephritis
93. Impairment of lung diffusion capacity in Schönlein-Henoch purpura
94. Alteration of lung diffusion capacity in IgA nephropathy
95. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy
96. IgA nephropathy associated with hepatitis B virus antigenemia
97. Renal deposition of cytomegalovirus antigen in immunoglobulin-A nephropathy
98. IgA nephropathy and hepatitis B virus: IgA nephropathy unrelated to hepatitis B surface antigenemia
99. Is Epstein-Barr virus involved in primary IgA nephropathy?
100. Circulating IgA, IgG and IgM class antibody against Haemophilus parainfluenzae antigens in patients with IgA nephropathy
101. IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli
102. Glomerular deposition of food antigens in IgA nephropathy
103. Serum-IgE bei Hauterkrankungen im Kindersalter
104. Possible pathogenic role of IgE in Henoch-Schönlein purpura
105. Incidence of atopy in 1gAN
106. Altered production of IgE and IgA induced by IL-4 in peripheral blood mononuclear cells from patients with IgA nephropathy
107. Serum immunoglobulin E in IgA nephropathy
108. Eosinophil cationic protein in Henoch-Schönlein purpura and in IgA nephropathy
109. Serum complement proteins in IgA nephropathy
110. Activation of complement in IgA nephropathy
111. Immunohistochemical study of the membrane attack complex of complement in IgA nephropathy
112. Activated complement C3: A potential novel predictor of progressive IgA nephropathy
113. Complement activation in Henoch-Schönlein purpura
114. Genetic factors in IgA nephropathy
115. Increase of in vivo and in vitro production of polyclonal IgA in patients and their family members with IgA nephropathy
116. C4 isotype deficiency in IgA nephropathy
117. Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region
118. Complement phenotypes in glomerulonephritis: Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpura
119. IgA nephritis associated with plasminogen abnormalities
120. 2-like activity in patients with IgA nephropathy and Henoch-Schönlein purpura
121. Elevation of von Willebrand factor levels in patients with IgA nephropathy: Effect of ACE inhibition
122. Von Willebrand factor and factor XIII in children with Henoch-Schönlein purpura
123. Circulating adhesion molecules ICAM-1, E-selectin and von Willebrand factor in Henoch-Schönlein purpura
124. Intraglomerular deposition of intact cross-linked fibrin in IgA nephropathy and Henoch-Schönlein nephritis
125. Immunopathology of the Renal Glomerulus
126. Studies on the mesangial handling of protein antigens: Influence of size, charge and biologic activity
127. The mesangial cell: A tissue culture view
128. Evidence for a specific IgA receptor in rat and human mesangial cells
129. IgA induced activation of human mesangial cells: Independent of FcαRI (CD 89)
130. Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10
131. Human mesangial cells in culture and in kidney sections fail to express Fc Alpha receptor (CD89)
132. Urinary levels of chemokines (MCAF/MCP-I, IL-8) reflect distinct disease activities and phases of human IgA nephropathy
133. Involvement of IL-6 in mesangial proliferative glomerulonephritis
134. Glomerular FcaR expression and disease activity in IgA nephropathy
135. Expression of PDGF and PDGF receptor mRNA in glomeruli in IgA nephropathy
136. PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis
137. The pathogenetic role of the coagulation process in rabbit Masugi nephritis
138. The ins and outs of glomerular crescent formation
139. Vasculitis
140. Cytokines responses of human blood monocytes stimulated with Igs
141. A role for mast cells in the development of adjuvant-induced vasculitis and arthritis
142. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice